Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate Abicipar Pegol for Safety and Treatment Effect in Participants With Neovascular Age-related Macular Degeneration (AMD)

ClinicalTrials.gov ID: NCT03539549

Public ClinicalTrials.gov record NCT03539549. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 5:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to evaluate abicipar pegol for safety and treatment effects in participants with neovascular age-related macular degeneration (AMD).

Study identification

NCT ID
NCT03539549
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Allergan
Industry
Enrollment
124 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 25, 2018 (Actual)
Primary completion
Feb 27, 2019 (Actual)
Completion
Feb 27, 2019 (Actual)
Last update posted
Aug 3, 2020

2018 – 2019

United States locations

U.S. sites
37
U.S. states
16
U.S. cities
35
Facility City State ZIP Site status
Barnet Dulaney Perkins Eye Center Phoenix Arizona 85016 —
Retina Associates Southwest, PC Tucson Arizona 85710 —
Win Retina Arcadia California 91006 —
Retina Consultants of Orange County Fullerton California 92835 —
Mark B. Kislinger, MD, Inc. Glendora California 91741 —
Atlantis Retina Institute (Atlantis Eyecare) Huntington Beach California 92647 —
N. California Retina Vitreous Associates Medical Group, INC. Mountain View California 94040 —
California Eye Specialists Medical Group, Inc Pasadena California 91107 —
Retinal Consultants Medical Group, Inc. Sacramento California 95819 —
Colorado Retina Associates Golden Colorado 80401 —
Retina Specialty Institute Pensacola Florida 32503 —
Retina Vitreous Associates of Florida St. Petersburg Florida 33711 —
Center for Retina and Macular Disease Winter Haven Florida 33880 —
Georgia Retina, P.C. Marietta Georgia 30060 —
Marietta Eye Clinic Marietta Georgia 30060 —
Gailey Eye Clinic Bloomington Illinois 61704 —
Raj K. Maturi, MD, PC Indianapolis Indiana 46290 —
Sabates Eye Center Leawood Kansas 66211 —
Sierra Eye Associates Reno Nevada 89502 —
Capital Region Retina, PLLC Albany New York 12206 —
Ophthalmic Consultants of Long Island Lynbrook New York 11580 —
Retina Associates of Western New York Rochester New York 14620 —
Retina Vitreous Surgeons of Central NY, P.C. Syracuse New York 13224 —
Cincinnati Eye Institute Cincinnati Ohio 45242 —
Pennsylvania Retina Specialists, P.C. Camp Hill Pennsylvania 17011 —
Charleston Neuroscience Institute Ladson South Carolina 29456 —
Black Hills Regional Eye Institute Rapid City South Dakota 57701 —
Retina Research Institute of Texas Abilene Texas 79606 —
Texas Retina Associates Arlington Texas 76012 —
Austin Retina Associates Austin Texas 78705 —
Texan Eye Austin Texas 78731 —
Retinal Consultants of Houston Houston Texas 77030 —
Premiere Retina Specialists Midland Texas 79706 —
Retinal Consultants of San Antonio San Antonio Texas 78240 —
Retina Consultants of Houston The Woodlands Texas 77384 —
Strategic Clinical Research Group, LLC Willow Park Texas 76087 —
Retina Institute of Virginia Richmond Virginia 23235 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03539549, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 3, 2020 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03539549 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →